BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 34087401)

  • 1. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
    Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
    J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
    Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
    Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the anti-NSCLC effects and mechanisms of gypenosides by metabolomics and network pharmacology analysis.
    Qi YS; Xie JB; Xie P; Duan Y; Ling YQ; Gu YL; Piao XL
    J Ethnopharmacol; 2021 Dec; 281():114506. PubMed ID: 34371113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
    Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
    J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
    Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
    J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
    Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the Potential Mechanisms of
    Qi Y; Ni S; Heng X; Qu S; Ge P; Zhao X; Yao Z; Guo R; Yang N; Zhang Q; Zhu H
    Drug Des Devel Ther; 2022; 16():325-342. PubMed ID: 35173416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
    Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
    J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1.
    Fu M; Liu Y; Cheng H; Xu K; Wang G
    J Ethnopharmacol; 2022 Feb; 284():114771. PubMed ID: 34737010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer.
    Ye B; Chen P; Lin C; Zhang C; Li L
    J Ethnopharmacol; 2023 Dec; 317():116815. PubMed ID: 37400006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics.
    Xu D; Wang X; Huang D; Chen B; Lin X; Liu A; Huang J
    J Ethnopharmacol; 2022 Mar; 286():114836. PubMed ID: 34793885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
    Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
    Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
    Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
    J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer.
    Zeng P; Wang F; Zhang J; Ur Rashid H; Li X; Zhang P; Luo Y; Wu X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14414. PubMed ID: 38230796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
    Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
    BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.